Search research articles
Contact Us
Filters
Showing results (361-370 of 441) with videos related to
Page
of 45
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2024
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Vilde Drageset Haakensen, Åsa Kristina Öjlert, Solfrid Thunold, et al.
Thorax
|
July 20, 2014
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Jenette Creaney, Ian M Dick, Tarek M Meniawy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma
Daniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 3, 2024
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma
Andrea S Wolf, Megan Eisele, Dorothy J Giroux, et al.
Neuro-Oncology
|
July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
Kathryn M Field, John Simes, Anna K Nowak, et al.
Oncoimmunology
|
October 6, 2018
Combination immune checkpoint blockade as an effective therapy for mesothelioma
Vanessa S Fear, Caitlin Tilsed, Jonathan Chee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 5, 2019
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial
Lauren R Olafson, Anna H Siddell, Kathryn M Field, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Anna K Nowak, Kari Chansky, David C Rice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
A K Nowak, A M Cook, A M McDonnell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma
Ritu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Page
of 45
Search research articles
Search
Showing results (361-370 of 441) with videos related to
Sort By:
Page
of 45
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2024
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Vilde Drageset Haakensen, Åsa Kristina Öjlert, Solfrid Thunold, et al.
Thorax
|
July 20, 2014
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Jenette Creaney, Ian M Dick, Tarek M Meniawy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma
Daniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 3, 2024
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma
Andrea S Wolf, Megan Eisele, Dorothy J Giroux, et al.
Neuro-Oncology
|
July 2, 2015
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
Kathryn M Field, John Simes, Anna K Nowak, et al.
Oncoimmunology
|
October 6, 2018
Combination immune checkpoint blockade as an effective therapy for mesothelioma
Vanessa S Fear, Caitlin Tilsed, Jonathan Chee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
October 5, 2019
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial
Lauren R Olafson, Anna H Siddell, Kathryn M Field, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Anna K Nowak, Kari Chansky, David C Rice, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
A K Nowak, A M Cook, A M McDonnell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 23, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for Revisions of the "T" Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural Mesothelioma
Ritu R Gill, Anna K Nowak, Dorothy J Giroux, et al.
Page
of 45